FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220905687> ?p ?o ?g. }

• W4220905687 endingPage "1027" @default.
• W4220905687 startingPage "1020" @default.
• W4220905687 abstract "Sulbactam and sulbactam-containing β-lactam antibiotics are often used in the treatment of Acinetobacter baumannii. We aimed to further examine the clinical efficacy of a cefoperazone/sulbactam anti-infective regimen in multidrug-resistant A. baumannii (MDRAB) lung infections.We conducted a retrospective analysis among patients with MDRAB lung infection and complete data who were treated at the geriatric intensive care unit of Jiangsu Province Hospital from January 2018 to December 2020. We collected general information, including age, sex, APACHE II score, anti-infective course, comorbid infections in other sites, other pathogens, cefoperazone/sulbactam regimen and concomitant medications, and adverse reactions. We used microbiological changes before and after treatment to assess microbiological efficacy, defined as microbial eradication and reduction.121 patients were included, among which 96 (79.34%) were men and 25 (20.66%) were women. The median age was 76 (interquartile range [IQR] 62.5-83) years, median APACHE II score was 22 (IQR 19-26), and median treatment course was 8 (IQR 5-12.5) days. Among these patients, tigecycline was concomitantly used in 52 patients and the sulbactam dose was increased to 4 g and above in 27 patients. The microbiological efficacy of conventional cefoperazone/sulbactam with/without tigecycline in MDRAB decreased with each consecutive year and a reduction in efficacy was linearly correlated with year, which was both statistically significant (p = 0.039, 0.030, respectively). In 2020, the microbiological efficacy of a higher sulbactam dose combined with tigecycline was 75%, which was a significant improvement over the conventional dose (p = 0.028). The 3-year data showed that the microbiological efficacy of conventional cefoperazone/sulbactam 3 g eight hourly (q8h) without tigecycline was 32% and efficacy increased to 57.9% when the sulbactam dose was increased. Hence, the increased sulbactam dose significantly improved efficacy in MDRAB lung infection (p = 0.049). Different doses of sulbactam combined with tigecycline increased the microbiological efficacy of MDRAB but the differences were not statistically significant.A cefoperazone/sulbactam-based anti-infective regimen showed some efficacy in MDRAB lung infection, but the microbiological efficacy of a cefoperazone/sulbactam 3 g q8h regimen decreased over time. Increasing the sulbactam dose to 4 g or more can improve efficacy. Minimum inhibitory concentration (MIC)-guided personalized medicine may be a future research direction." @default.
• W4220905687 created "2022-04-03" @default.
• W4220905687 creator A5054241615 @default.
• W4220905687 creator A5064141461 @default.
• W4220905687 creator A5081461782 @default.
• W4220905687 date "2022-03-14" @default.
• W4220905687 modified "2023-09-23" @default.
• W4220905687 title "Observation of clinical efficacy of the cefoperazone/sulbactam anti‐infective regimen in the treatment of multidrug‐resistant <i>Acinetobacter baumannii</i> lung infection" @default.
• W4220905687 cites W1980961631 @default.
• W4220905687 cites W2006881751 @default.
• W4220905687 cites W2016624659 @default.
• W4220905687 cites W2022936864 @default.
• W4220905687 cites W2023428631 @default.
• W4220905687 cites W2031204159 @default.
• W4220905687 cites W2095077206 @default.
• W4220905687 cites W2104582297 @default.
• W4220905687 cites W2158229527 @default.
• W4220905687 cites W2170959038 @default.
• W4220905687 cites W2288514582 @default.
• W4220905687 cites W2589098074 @default.
• W4220905687 cites W2782017448 @default.
• W4220905687 cites W2783285700 @default.
• W4220905687 cites W2896960072 @default.
• W4220905687 cites W4250421841 @default.
• W4220905687 cites W4250496609 @default.
• W4220905687 cites W4377077039 @default.
• W4220905687 doi "https://doi.org/10.1111/jcpt.13638" @default.
• W4220905687 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35285526" @default.
• W4220905687 hasPublicationYear "2022" @default.
• W4220905687 type Work @default.
• W4220905687 citedByCount "2" @default.
• W4220905687 countsByYear W42209056872023 @default.
• W4220905687 crossrefType "journal-article" @default.
• W4220905687 hasAuthorship W4220905687A5054241615 @default.
• W4220905687 hasAuthorship W4220905687A5064141461 @default.
• W4220905687 hasAuthorship W4220905687A5081461782 @default.
• W4220905687 hasConcept C119060515 @default.
• W4220905687 hasConcept C126322002 @default.
• W4220905687 hasConcept C141071460 @default.
• W4220905687 hasConcept C2776315533 @default.
• W4220905687 hasConcept C2776376669 @default.
• W4220905687 hasConcept C2776432923 @default.
• W4220905687 hasConcept C2777027569 @default.
• W4220905687 hasConcept C2777637488 @default.
• W4220905687 hasConcept C2778478555 @default.
• W4220905687 hasConcept C2779631663 @default.
• W4220905687 hasConcept C2781413609 @default.
• W4220905687 hasConcept C501593827 @default.
• W4220905687 hasConcept C523546767 @default.
• W4220905687 hasConcept C54355233 @default.
• W4220905687 hasConcept C71924100 @default.
• W4220905687 hasConcept C86803240 @default.
• W4220905687 hasConcept C89423630 @default.
• W4220905687 hasConcept C90924648 @default.
• W4220905687 hasConcept C94665300 @default.
• W4220905687 hasConceptScore W4220905687C119060515 @default.
• W4220905687 hasConceptScore W4220905687C126322002 @default.
• W4220905687 hasConceptScore W4220905687C141071460 @default.
• W4220905687 hasConceptScore W4220905687C2776315533 @default.
• W4220905687 hasConceptScore W4220905687C2776376669 @default.
• W4220905687 hasConceptScore W4220905687C2776432923 @default.
• W4220905687 hasConceptScore W4220905687C2777027569 @default.
• W4220905687 hasConceptScore W4220905687C2777637488 @default.
• W4220905687 hasConceptScore W4220905687C2778478555 @default.
• W4220905687 hasConceptScore W4220905687C2779631663 @default.
• W4220905687 hasConceptScore W4220905687C2781413609 @default.
• W4220905687 hasConceptScore W4220905687C501593827 @default.
• W4220905687 hasConceptScore W4220905687C523546767 @default.
• W4220905687 hasConceptScore W4220905687C54355233 @default.
• W4220905687 hasConceptScore W4220905687C71924100 @default.
• W4220905687 hasConceptScore W4220905687C86803240 @default.
• W4220905687 hasConceptScore W4220905687C89423630 @default.
• W4220905687 hasConceptScore W4220905687C90924648 @default.
• W4220905687 hasConceptScore W4220905687C94665300 @default.
• W4220905687 hasIssue "7" @default.
• W4220905687 hasLocation W42209056871 @default.
• W4220905687 hasLocation W42209056872 @default.
• W4220905687 hasOpenAccess W4220905687 @default.
• W4220905687 hasPrimaryLocation W42209056871 @default.
• W4220905687 hasRelatedWork W2092986910 @default.
• W4220905687 hasRelatedWork W2145305640 @default.
• W4220905687 hasRelatedWork W2328573429 @default.
• W4220905687 hasRelatedWork W2388827549 @default.
• W4220905687 hasRelatedWork W2511190969 @default.
• W4220905687 hasRelatedWork W2783285700 @default.
• W4220905687 hasRelatedWork W2790114569 @default.
• W4220905687 hasRelatedWork W2980761243 @default.
• W4220905687 hasRelatedWork W3010677489 @default.
• W4220905687 hasRelatedWork W3028767907 @default.
• W4220905687 hasVolume "47" @default.
• W4220905687 isParatext "false" @default.
• W4220905687 isRetracted "false" @default.
• W4220905687 workType "article" @default.